About: Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
Creator	Dziedzic, Arkadiusz Kubina, Robert
source	Medline; PMC
abstract	Validated and accurate laboratory testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a crucial part of the timely management of Coronavirus Disease 2019 (COVID-19) disease, supporting the clinical decision-making process for infection control at the healthcare level and detecting asymptomatic cases. This would facilitate an appropriate treatment, a prompt isolation and consequently deceleration of the pandemic. Various laboratory tests can identify the genetic material of SARS-CoV-2 that causes COVID-19 in specimens, or specific anti-viral antibodies in blood/serum. Due to the current pandemic situation, a development of point-of-care diagnostics (POCD) allows us to substantially accelerate taking clinical decisions and implement strategic planning at the national level of preventative measures. This review summarizes and compares the available POCD and those currently under development, including quantitative reverse transcription PCR (RT-qPCR), serology immunoassays (SIAs) and protein microarray method (PMM) designed for standard and rapid COVID-19 diagnosis.
has issue date	2020-06-26(xsd:dateTime)
bibo:doi	10.3390/diagnostics10060434
bibo:pmid	32604919
has license	cc-by
sha1sum (hex)	41d109c12cb55aabf8f1024e4f6952a7c0cb327a
schema:url	https://doi.org/10.3390/diagnostics10060434
resource representing a document's title	Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
has PubMed Central identifier	PMC7345211
has PubMed identifier	32604919
schema:publication	Diagnostics (Basel)
resource representing a document's body	covid:41d109c12cb55aabf8f1024e4f6952a7c0cb327a#body_text
is schema:about of	named entity 'MANAGEMENT' named entity 'ISOLATION' named entity 'METHOD' named entity 'DECISIONS' named entity 'ASYMPTOMATIC' named entity 'DECELERATION' named entity 'CURRENTLY' named entity 'CLINICAL' named entity 'CASES' named entity 'SEROLOGY' named entity 'point-of-care diagnostics' named entity 'COVID' named entity 'SIAs' named entity 'decision-making process' named entity 'POCD' named entity 'Serological Tests' named entity 'fluorescent' named entity 'SARS' named entity 'immunochromatographic' named entity 'antibodies' named entity 'colorimetric' named entity 'PCR technique' named entity 'Food and Drug Administration' named entity 'window period' named entity 'IgG' named entity 'gene' named entity 'SARS' named entity 'IVD' named entity 'antigen' named entity 'high-affinity' named entity 'virus' named entity 'gene' named entity 'reaction time' named entity 'nitrocellulose' named entity 'virus' named entity 'antibody' named entity 'Xpert Xpress' named entity 'microtitration' named entity 'virus' named entity 'virus' named entity 'RT-qPCR' named entity 'gene' named entity 'IVD' named entity 'infection' named entity 'COVID' named entity 'immunochromatographic' named entity 'COVID' named entity 'laboratory tests' named entity 'Cepheid' named entity 'antibodies' named entity 'COVID' named entity 'antibodies' named entity 'rapid diagnostic tests' named entity 'cerebrospinal fluid' named entity 'antibodies' named entity 'cross-react' named entity 'SARS-CoV-2' named entity 'SARS' named entity 'SARS-CoV-2' named entity 'test quality' named entity 'immunology' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'influenza' named entity 'immunoassays' named entity 'RT-qPCR' named entity 'nitrocellulose' named entity 'cross-reactivity' named entity 'gene' named entity 'genetic material' named entity 'tracheal' named entity 'antibodies' named entity 'genetic tests' named entity 'inflammation' named entity 'pharynx' named entity 'respiratory tract' named entity 'antigens' named entity 'infection' named entity 'sensitivity and specificity' named entity 'cDNA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software